Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 21;83(18):10798-10804.
doi: 10.1021/acs.joc.8b01519. Epub 2018 Aug 23.

Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors

An Xiao  1 , Teri J Slack  1 , Yanhong Li  1 , Dashuang Shi  2 , Hai Yu  1 , Wanqing Li  1 , Yang Liu  2 , Xi Chen  1
Affiliations

Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors

An Xiao et al. J Org Chem. .

Abstract

Streptococcus pneumoniae sialidase SpNanB is an intramolecular trans-sialidase (IT-sialidase) and a virulence factor that is essential for streptococcal infection of the upper and lower respiratory tract. SpNanB catalyzes the formation of 2,7-anhydro- N-acetylneuraminic acid (2,7-anhydro-Neu5Ac), a potential prebiotic that can be used as the sole carbon source of a common human gut commensal anaerobic bacterium. We report here the development of an efficient one-pot multienzyme (OPME) system for synthesizing 2,7-anhydro-Neu5Ac and its derivatives. Based on a crystal structure analysis, an N-cyclohexyl derivative of 2,7-anhydro-neuraminic acid was designed, synthesized, and shown to be a selective inhibitor against SpNanB and another Streptococcus pneumoniae sialidase SpNanC. This study demonstrates a new strategy of synthesizing 2,7-anhydro-sialic acids in a gram scale and the potential application of their derivatives as selective sialidase inhibitors.

PubMed Disclaimer

Conflict of interest statement

Notes

The authors declare no competing financial interest.

Figures

Fig. 1.
Fig. 1.
Structures of enzymatically synthesized 2,7-anhydro-Neu5Ac (1) and its chemoenzymatically synthesized derivatives 2–4.
Fig. 2.
Fig. 2.
Superimposition of 2,7-anhydro-Neu5Ac (in brown sticks), CHES (in pink sticks), and 2-[(3-chlorobenzyl)ammonio)ethanesulfonate (in pale-blue sticks). The coordinates were extracted from Protein Data Bank (PDB IDs: 2WV1, 2VW2, and 4FPF).
Scheme 1.
Scheme 1.
One-pot multienzyme (OPME) synthesis of 2,7-anhydro-Neu5Ac (1) and 2,7-anhydro-Neu5TFA (2).
Scheme 2.
Scheme 2.
Synthesis of 2,7-anhydro-Neu5Cyclohexyl (4) from 2,7-anhydro-Neu5TFA (2).
See this image and copyright information in PMC

References

    1. Fine MJ; Smith MA; Carson CA; Mutha SS; Sankey SS; Weissfeld LA; Kapoor WN Prognosis And Outcomes of Patients with Community-Acquired Pneumonia: A Meta-Analysis. JAMA 1996, 275, 134–141. - PubMed
    1. Reichler MR; Allphin AA; Breiman RF; Schreiber JR; Arnold JE; McDougal LK; Facklam RR; Boxerbaum B; May D; Walton RO The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio. J. Infect. Dis. 1992, 166, 1346–1353. - PubMed
    1. Camara M; Boulnois G; Andrew P; Mitchell T A Neuraminidase from Streptococcus pneumoniae has the Features of a Surface Protein. Infect. Immun. 1994, 62, 3688–3695. - PMC - PubMed
    1. Xu G; Li X; Andrew PW; Taylor GL Structure of the Catalytic Domain of Streptococcus pneumoniae Sialidase NanA. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2008, 64, 772–775. - PMC - PubMed
    1. Camara M; Mitchell TJ; Andrew PW; Boulnois GJ Streptococcus pneumoniae Produces at least Two Distinct Enzymes with Neuraminidase Activity: Cloning and Expression of a Second Neuraminidase Gene in Escherichia coli. Infect. Immun. 1991, 59, 2856–2858. - PMC - PubMed

Publication types

MeSH terms